Assyro AI

Orange Book product · Generic (ANDA)

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE

Generic (ANDA)ANDA 217385DISCN TORRENT

At a glance

Dec 14, 2023

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 14, 2023

    2 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE

Strength

5MG;2.5MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 217385

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.